Harry F. Hixson, Jr.

2015

In 2015, Harry F. Hixson, Jr. earned a total compensation of $482.8K as Director and Former Interim Chief Executive Officer and Principal Financial Officer at Arena Pharmaceuticals, a 119% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$75,000
Salary$187,965
Stock Awards$164,996
Other$54,847
Total$482,808

Hixson received $188K in salary, accounting for 39% of the total pay in 2015.

Hixson also received $75K in non-equity incentive plan, $165K in stock awards and $54.8K in other compensation.

Rankings

In 2015, Harry F. Hixson, Jr.'s compensation ranked 10,980th out of 13,638 executives tracked by ExecPay. In other words, Hixson earned more than 19.5% of executives.

ClassificationRankingPercentile
All
10,980
out of 13,638
20th
Division
Manufacturing
4,194
out of 5,187
19th
Major group
Chemicals And Allied Products
1,545
out of 1,857
17th
Industry group
Drugs
1,275
out of 1,531
17th
Industry
Pharmaceutical Preparations
988
out of 1,179
16th
Source: SEC filing on April 28, 2017.

Hixson's colleagues

We found six more compensation records of executives who worked with Harry F. Hixson, Jr. at Arena Pharmaceuticals in 2015.

2015

Jack Lief

Arena Pharmaceuticals

Chief Executive Officer

2015

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2015

Steven Spector

Arena Pharmaceuticals

General Counsel

2015

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

2015

Craig Audet

Arena Pharmaceuticals

Former Senior Vice President, Operations and Head of Global Regulatory Affairs

2015

Robert Hoffman

Arena Pharmaceuticals

Chief Financial Officer

You may also like